KIN - Kindred Biosciences - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $4.41. This is a potential upside of $4.41 (0%) from yesterday's end of day stock price of $0.

Kindred Biosciences's activity chart (see below) currently has 21 price targets and 16 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.17% with an average time for these price targets to be met of 189.88 days.

Most recent stock forecast was given by BEN HAYNOR from ALLIANCE GLOBAL PARTNERS on 23-Aug-2021. First documented stock forecast 17-Nov-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$15.25

3 years 3 months 8 days ago
(23-Aug-2021)

2/4 (50%)

$10.95 (254.65%)

332

Hold

3 years 5 months 14 days ago
(17-Jun-2021)

2/4 (50%)

$4.96 (35.33%)

30

Hold

$9

$-0.25 (-2.70%)

$12

3 years 5 months 14 days ago
(17-Jun-2021)

0/4 (0%)

$6.82 (88.53%)

Hold

$9.25

$11

3 years 5 months 15 days ago
(16-Jun-2021)

1/5 (20%)

$0.02 (0.22%)

69

Hold

$9

$-0.25 (-2.70%)

3 years 5 months 15 days ago
(16-Jun-2021)

0/2 (0%)

$3.3 (36.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KIN (Kindred Biosciences) average time for price targets to be met?

On average it took 189.88 days on average for the stock forecasts to be realized with a an average price target met ratio 44.17

Which analyst has the current highest performing score on KIN (Kindred Biosciences) with a proven track record?

ALEX ARFAEI

Which analyst has the current lower performing score on KIN (Kindred Biosciences) with a proven track record?

NATHAN WEINSTEIN

Which analyst has the most public recommendations on KIN (Kindred Biosciences)?

Alex Arfaei has 10 price targets and 9 ratings on KIN

Which analyst is the currently most bullish on KIN (Kindred Biosciences)?

Swayampakula Ramakanth with highest potential upside - $0

Which analyst is the currently most reserved on KIN (Kindred Biosciences)?

Alex Arfaei with lowest potential downside - -$4.25

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?